4D Molecular Therapeutics... (FDMT)
2.60
-0.16 (-5.80%)
At close: Apr 10, 2025, 9:47 AM
13F Institute Ownership
Total Institutes of 146 in 4D Molecular Therapeutics expanded their positions with an increase of 6 investors compared to the previous quarter. A reduction of 10.84M shares, as total invested capital declined by $362.57M with ownership percentage dropping from 103.86% to 84.35%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.271
0.27
Call Flow 120,500
79%
Put Flow 32,700
21%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Blackrock, Inc. | 8.86% | 4.92M | +1.08% | 27.41M | < 0.01% |
| Ra Capital Management, L.p. | 8.21% | 4.56M | -10.49% | 25.42M | 0.34% |
| Goldman Sachs Group Inc | 7.70% | 4.27M | +19.05% | 23.81M | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.